For most Canadians starting GLP-1 therapy today, Semaglutide hits the sweet spot of proven efficacy, established long-term safety, demonstrated cardiovascular protection, and reasonable tolerability
Detoxifies the body and improves skin clarity
Thus, the decision to view semaglutide primarily as a "diabetic medication" goes beyond just semantics it reveals our subtle biases and has tangible downstream implications
Quite often Primary Care Providers dont start medications and primarily stress lifestyle changes
Nonobese Oregonians seeking svelter figures are likely to hit dead ends at reputable medical centers, which are historically cautious and slow to adopt Hollywood and Manhattans trendier, FDA-approved, nonessential treatments
If someone has established cardiovascular disease and obesity or overweight, Wegovy can be prescribed under that indication, Dr